entertainment -WSS

entertainment

author：focus 2025-09-29 13:31:23 - browse：5

Among the pharmaceutical companies’ many objections to the Biden administration’s drug pricing program is a set of provisions the industry says will warp how cancer drugs are developed. On Wednesday, AstraZeneca CEO Pascal Soriot proposed a new solution.

“What we were asking — and are asking now — is a very simple fix,” said Soriot at the STAT Future Summit, saying that “the impact on health care costs would be very marginal.”

The problem, executives say, is that companies developing cancer drugs today generally start small and then go big. They seek approval first in a small setting, such as patients who have exhausted all other therapies, where it’s easiest in terms of trial size and length to show a benefit. Then they go into larger settings, such as newly diagnosed patients, where studies take longer but the revenue potential is much higher.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Families look for replacement for GSK asthma drug Flovent

hotspot

WSS

Study: Lilly Alzheimer's therapy slowed patients' cognitive decline

Fetal cell organoids grown from amniotic fluid, study finds

Change Healthcare: What is it, why does its cyberattack matter?

$1 billion proposal to grow Boston, Massachusetts biotech

Weight bias in eating disorder treatment complicated by new weight loss drugs

Why we need to separate burnout from moral injury in health care

hotspot

entertainment

hotspot

Drug repurposing or repositioning? The language matters

3 hurdles to bringing medical devices to the U.S. market

The high cost of giving birth even with insurance

New guidelines on severe brain injury complicate already difficult decisions

In Memoriam: Notable people who died in 2023

The science behind Janet Jackson's pregnancy at 49

Virginia high school admissions case could be legal follow

The strategy behind pharma's lawsuits over drug pricing reform

Peter Hotez and the public health issue of online harassment

CDC concerned about possible undetected monkeypox spread in U.K.

knowledge

CDC concerned about possible undetected monkeypox spread in U.K.

Study: Lilly Alzheimer's therapy slowed patients' cognitive decline

State of the Union pitch: Bigger Medicare drug price negotiations

Weight bias in eating disorder treatment complicated by new weight loss drugs

Why we need to separate burnout from moral injury in health care

Ozempic has benefits for kidney disease as well as diabetes

focus

hotspot

hotspot

Wikipedia